---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-012630"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T22:07:23.296437+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs appoints Bill White as CFO effective May 23, 2022

## Summary
- Bill White, 61, replaces Monica Brady, who becomes CAO and CFO of subsidiary ProPhase Diagnostics.
- White previously CFO/COO of Intellicheck (IDN); over 30 years financial management experience.
- Salary $350k; minimum 2022 bonus $50k; inducement option for 400k shares at $6.74, vesting 4 years.
- Severance: 6 months salary if terminated without cause before 1 year; 12 months after 1 year.
- Inducement option exempt from stockholder approval per Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001493152-22-012630
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-012630
- JSON: https://secwatch.observer/filing/0001493152-22-012630.json
- Plain text: https://secwatch.observer/filing/0001493152-22-012630.txt

## Key facts
- Executive change
  Bill White was appointed as Chief Financial Officer at ProPhase Labs, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On May 9, 2022, ProPhase Labs, Inc. (the “Company”) announced that it will appoint Bill White, age 61, as Chief Financial Officer of the Company, effective May 23, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm
- Executive change
  Monica Brady changed role as Chief Accounting Officer and Chief Financial Officer of subsidiary at ProPhase Labs, Inc..
  - Action: replaced
  - Role: Chief Accounting Officer and Chief Financial Officer of subsidiary
  source text: Ms. Brady will remain with the Company and continue to serve as the Company’s Chief Accounting Officer, and Chief Financial Officer of the Company’s wholly-owned subsidiary, ProPhase Diagnostics, Inc., as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315222012630/0001493152-22-012630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.